Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 199

1.

Thrombocytosis and immunohistochemical expression of connexin 43 at diagnosis predict survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy.

Du G, Yang Y, Zhang Y, Sun T, Liu W, Wang Y, Li J, Zhang H.

Cancer Chemother Pharmacol. 2013 Apr;71(4):893-904. doi: 10.1007/s00280-013-2080-6. Epub 2013 Jan 26. Erratum in: Cancer Chemother Pharmacol. 2013 Jul;72(1):275. Yang, Yingming [corrected to Yang, Yiming].

PMID:
23355038
[PubMed - indexed for MEDLINE]
2.

The role of expression and polymorphism of the BAG-1 gene in response to platinum-based chemotherapeutics in NSCLC.

Wang YD, Ha MW, Cheng J, Zhang WL, Cong X, Tong CY, Sun J.

Oncol Rep. 2012 Apr;27(4):979-86. doi: 10.3892/or.2011.1591. Epub 2011 Dec 13.

PMID:
22179630
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Prognostic factors for second-line treatment of advanced non-small-cell lung cancer: retrospective analysis at a single institution.

Inal A, Kaplan MA, Kucukoner M, Urakci Z, Karakus A, Isikdogan A.

Asian Pac J Cancer Prev. 2012;13(4):1281-4.

PMID:
22799319
[PubMed - indexed for MEDLINE]
Free Article
4.

Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.

Kim SH, Lee GW, Lee MJ, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS, Kim IS, Lee S, Oh SY.

Lung Cancer. 2012 Sep;77(3):578-84. doi: 10.1016/j.lungcan.2012.04.016. Epub 2012 May 18.

PMID:
22608006
[PubMed - indexed for MEDLINE]
5.

Genetic variants of NBS1 predict clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer in Chinese.

Xu JL, Hu LM, Huang MD, Zhao W, Yin YM, Hu ZB, Ma HX, Shen HB, Shu YQ.

Asian Pac J Cancer Prev. 2012;13(3):851-6.

PMID:
22631660
[PubMed - indexed for MEDLINE]
Free Article
6.

Expression of MRP1, BCRP, LRP, and ERCC1 in advanced non-small-cell lung cancer: correlation with response to chemotherapy and survival.

Li J, Li ZN, Du YJ, Li XQ, Bao QL, Chen P.

Clin Lung Cancer. 2009 Nov;10(6):414-21. doi: 10.3816/CLC.2009.n.078.

PMID:
19900859
[PubMed - indexed for MEDLINE]
7.

Prognostic factors in elderly patients with advanced non-small cell lung cancer treated with first-line cisplatin-based chemotherapy: a retrospective analysis of single institution.

Inal A, Kaplan MA, Kucukoner M, Karakus A, Isikdogan A.

J BUON. 2012 Jul-Sep;17(3):533-6.

PMID:
23033295
[PubMed - indexed for MEDLINE]
8.

Tumor-infiltrating lymphocytes predict response to chemotherapy in patients with advance non-small cell lung cancer.

Liu H, Zhang T, Ye J, Li H, Huang J, Li X, Wu B, Huang X, Hou J.

Cancer Immunol Immunother. 2012 Oct;61(10):1849-56. Epub 2012 Mar 29.

PMID:
22456757
[PubMed - indexed for MEDLINE]
9.

High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers.

Hou X, Li Y, Luo RZ, Fu JH, He JH, Zhang LJ, Yang HX.

Eur J Surg Oncol. 2012 Jun;38(6):523-30. doi: 10.1016/j.ejso.2012.02.180. Epub 2012 Mar 21.

PMID:
22440742
[PubMed - indexed for MEDLINE]
10.

Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.

Chen P, Li J, Ge LP, Dai CH, Li XQ.

Respirology. 2010 Apr;15(3):501-9. doi: 10.1111/j.1440-1843.2010.01710.x. Epub 2010 Feb 24.

PMID:
20210890
[PubMed - indexed for MEDLINE]
11.

Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapy.

Yao Y, Yuan D, Liu H, Gu X, Song Y.

Cancer Immunol Immunother. 2013 Mar;62(3):471-9. doi: 10.1007/s00262-012-1347-9. Epub 2012 Sep 18.

PMID:
22986452
[PubMed - indexed for MEDLINE]
12.

Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen.

Zhao J, Zhao M, Jin B, Yu P, Hu X, Teng Y, Zhang J, Luo Y, Zhang L, Zheng S, Zhou Q, Li H, Liu Y, Qu X.

BMC Cancer. 2012 Aug 1;12:330. doi: 10.1186/1471-2407-12-330.

PMID:
22852778
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience.

Kefeli U, Kaya S, Ustaalioglu BO, Bilici A, Kefeli AU, Yildirim ME, Seker M, Yilmaz B, Salepci T, Uygun K, Gumus M.

Med Oncol. 2011 Sep;28(3):661-6. doi: 10.1007/s12032-010-9504-5. Epub 2010 Mar 31.

PMID:
20354816
[PubMed - indexed for MEDLINE]
14.

EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer.

Wu M, Zhao J, Song SW, Zhuo M, Wang X, Bai H, Wang S, Yang L, An T, Zhang Y, Duan J, Wang Y, Guo Q, Liu X, Liu N, Wang J.

Lung Cancer. 2010 Mar;67(3):343-7. doi: 10.1016/j.lungcan.2009.04.011. Epub 2009 May 27.

PMID:
19477549
[PubMed - indexed for MEDLINE]
15.

Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy.

Ota S, Ishii G, Goto K, Kubota K, Kim YH, Kojika M, Murata Y, Yamazaki M, Nishiwaki Y, Eguchi K, Ochiai A.

Lung Cancer. 2009 Apr;64(1):98-104. doi: 10.1016/j.lungcan.2008.07.014. Epub 2008 Sep 26.

PMID:
18823676
[PubMed - indexed for MEDLINE]
17.

Pemetrexed monotherapy versus pemetrexed plus platinum combination as second-line treatment for advanced non-small cell lung cancer.

Zhang YF, Chen ZW, Lu S.

Chin Med J (Engl). 2009 Oct 20;122(20):2472-6.

PMID:
20079162
[PubMed - indexed for MEDLINE]
Free Article
18.

Initial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancer.

He L, Teng Y, Jin B, Zhao M, Yu P, Hu X, Zhang J, Li S, Gao Y, Liu Y.

BMC Cancer. 2010 Dec 14;10:681. doi: 10.1186/1471-2407-10-681.

PMID:
21156055
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Prognostic factors in older patients with advanced non-small cell lung cancer in China.

Su Q, Sun YP, Liu YH, Li Z, Yang HY, Sun ZG, Cao BW, Jia JH.

Tumori. 2014 Jan-Feb;100(1):69-74. doi: 10.1700/1430.15818.

PMID:
24675494
[PubMed - indexed for MEDLINE]
20.

Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer.

Yoh K, Ishii G, Yokose T, Minegishi Y, Tsuta K, Goto K, Nishiwaki Y, Kodama T, Suga M, Ochiai A.

Clin Cancer Res. 2004 Mar 1;10(5):1691-7.

PMID:
15014021
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk